Agilent Technologies (NYSE:A) Price Target Lowered to $160.00 at JPMorgan Chase & Co.

Agilent Technologies (NYSE:A) had its price target decreased by investment analysts at JPMorgan Chase & Co. from $165.00 to $160.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical research company’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 15.85% from the company’s previous close.

A has been the subject of several other reports. TD Cowen upped their target price on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. UBS Group increased their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Citigroup upped their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a report on Monday, August 26th. Finally, Barclays upped their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $143.40.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $138.11 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company has a market capitalization of $39.68 billion, a PE ratio of 31.25, a P/E/G ratio of 5.91 and a beta of 1.07. The company has a 50 day moving average price of $137.72 and a 200-day moving average price of $137.43. Agilent Technologies has a fifty-two week low of $124.10 and a fifty-two week high of $155.35.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Institutional Trading of Agilent Technologies

Large investors have recently bought and sold shares of the stock. Crewe Advisors LLC increased its holdings in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory acquired a new position in Agilent Technologies in the 3rd quarter worth approximately $28,000. Ridgewood Investments LLC purchased a new position in Agilent Technologies during the 2nd quarter worth approximately $29,000. Ashton Thomas Securities LLC acquired a new stake in Agilent Technologies during the 3rd quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC boosted its holdings in shares of Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.